• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

高胆固醇血症引起的高密度脂蛋白功能障碍是可以逆转的:饮食和他汀类药物治疗对临床前动物模型的影响。

Hypercholesterolemia-Induced HDL Dysfunction Can Be Reversed: The Impact of Diet and Statin Treatment in a Preclinical Animal Model.

机构信息

Cardiovascular Program ICCC, Institut de Recerca, Hospital Santa Creu i Sant Pau, IIB Sant Pau, 08025 Barcelona, Spain.

Faculty of Medicine, University of Barcelona (UB), 08036 Barcelona, Spain.

出版信息

Int J Mol Sci. 2022 Aug 2;23(15):8596. doi: 10.3390/ijms23158596.

DOI:10.3390/ijms23158596
PMID:35955730
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9368958/
Abstract

High-density lipoproteins (HDL) undergo adverse remodeling and loss of function in the presence of comorbidities. We assessed the potential of lipid-lowering approaches (diet and rosuvastatin) to rescue hypercholesterolemia-induced HDL dysfunction. Hypercholesterolemia was induced in 32 pigs for 10 days. Then, they randomly received one of the 30-day interventions: (I) hypercholesterolemic (HC) diet; (II) HC diet + rosuvastatin; (III) normocholesterolemic (NC) diet; (IV) NC diet + rosuvastatin. We determined cholesterol efflux capacity (CEC), antioxidant potential, HDL particle number, HDL apolipoprotein content, LDL oxidation, and lipid levels. Hypercholesterolemia time-dependently impaired HDL function (−62% CEC, −11% antioxidant index (AOI); p < 0.01), increased HDL particles numbers 2.8-fold (p < 0.0001), reduced HDL-bound APOM (−23%; p < 0.0001), and increased LDL oxidation 1.7-fold (p < 0.0001). These parameters remained unchanged in animals on HC diet alone up to day 40, while AOI deteriorated up to day 25 (−30%). The switch to NC diet reversed HDL dysfunction, restored apolipoprotein M content and particle numbers, and normalized cholesterol levels at day 40. Rosuvastatin improved HDL, AOI, and apolipoprotein M content. Apolipoprotein A-I and apolipoprotein C-III remained unchanged. Lowering LDL-C levels with a low-fat diet rescues HDL CEC and antioxidant potential, while the addition of rosuvastatin enhances HDL antioxidant capacity in a pig model of hypercholesterolemia. Both strategies restore HDL-bound apolipoprotein M content.

摘要

高密度脂蛋白(HDL)在合并症存在的情况下会发生不利的重构和功能丧失。我们评估了降脂方法(饮食和瑞舒伐他汀)恢复高胆固醇血症诱导的 HDL 功能障碍的潜力。在 32 头猪中诱导高胆固醇血症 10 天。然后,它们随机接受以下 30 天干预措施之一:(I)高胆固醇血症(HC)饮食;(II)HC 饮食+瑞舒伐他汀;(III)正常胆固醇血症(NC)饮食;(IV)NC 饮食+瑞舒伐他汀。我们测定了胆固醇流出能力(CEC)、抗氧化潜力、HDL 颗粒数、HDL 载脂蛋白含量、LDL 氧化和脂质水平。高胆固醇血症使 HDL 功能呈时间依赖性受损(CEC 降低 62%,抗氧化指数(AOI)降低 11%;p < 0.01),HDL 颗粒数增加 2.8 倍(p < 0.0001),HDL 结合的 APOM 减少 23%(p < 0.0001),LDL 氧化增加 1.7 倍(p < 0.0001)。在单独给予 HC 饮食的动物中,这些参数在第 40 天之前保持不变,而 AOI 在第 25 天恶化(降低 30%)。转换为 NC 饮食可逆转 HDL 功能障碍,恢复载脂蛋白 M 含量和颗粒数,并使胆固醇水平在第 40 天恢复正常。瑞舒伐他汀可改善 HDL、AOI 和载脂蛋白 M 含量。载脂蛋白 A-I 和载脂蛋白 C-III 保持不变。低脂饮食降低 LDL-C 水平可挽救 HDL 的 CEC 和抗氧化潜力,而瑞舒伐他汀可增强高胆固醇血症猪模型中 HDL 的抗氧化能力。两种策略都可恢复 HDL 结合的载脂蛋白 M 含量。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f712/9368958/93b9c172496e/ijms-23-08596-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f712/9368958/02cf26cef072/ijms-23-08596-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f712/9368958/4f8012bb9e65/ijms-23-08596-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f712/9368958/57e0b13b64f6/ijms-23-08596-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f712/9368958/7f7b980a0892/ijms-23-08596-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f712/9368958/93b9c172496e/ijms-23-08596-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f712/9368958/02cf26cef072/ijms-23-08596-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f712/9368958/4f8012bb9e65/ijms-23-08596-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f712/9368958/57e0b13b64f6/ijms-23-08596-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f712/9368958/7f7b980a0892/ijms-23-08596-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f712/9368958/93b9c172496e/ijms-23-08596-g005.jpg

相似文献

1
Hypercholesterolemia-Induced HDL Dysfunction Can Be Reversed: The Impact of Diet and Statin Treatment in a Preclinical Animal Model.高胆固醇血症引起的高密度脂蛋白功能障碍是可以逆转的:饮食和他汀类药物治疗对临床前动物模型的影响。
Int J Mol Sci. 2022 Aug 2;23(15):8596. doi: 10.3390/ijms23158596.
2
Cholesterol Efflux Capacity, High-Density Lipoprotein Particle Number, and Incident Cardiovascular Events: An Analysis From the JUPITER Trial (Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin).胆固醇流出能力、高密度脂蛋白颗粒数量与心血管事件发生率:来自JUPITER试验(他汀类药物在预防中的应用依据:一项评估瑞舒伐他汀的干预试验)的分析
Circulation. 2017 Jun 20;135(25):2494-2504. doi: 10.1161/CIRCULATIONAHA.116.025678. Epub 2017 Apr 27.
3
Platelet tissue factor activity and membrane cholesterol are increased in hypercholesterolemia and normalized by rosuvastatin, but not by atorvastatin.在高胆固醇血症中,血小板组织因子活性和膜胆固醇增加,而瑞舒伐他汀可使其正常化,但阿托伐他汀则不行。
Atherosclerosis. 2017 Feb;257:164-171. doi: 10.1016/j.atherosclerosis.2016.12.019. Epub 2016 Dec 16.
4
Atherogenic Lipoprotein Subfractions Determined by Ion Mobility and First Cardiovascular Events After Random Allocation to High-Intensity Statin or Placebo: The Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin (JUPITER) Trial.通过离子淌度测定的致动脉粥样硬化脂蛋白亚组分以及随机分配至高强度他汀类药物或安慰剂组后的首次心血管事件:他汀类药物用于预防的理由:一项评估瑞舒伐他汀的干预试验(JUPITER试验)
Circulation. 2015 Dec 8;132(23):2220-9. doi: 10.1161/CIRCULATIONAHA.115.016857. Epub 2015 Sep 25.
5
A Comparison of Statin Therapies in Hypercholesterolemia in Women: A Subgroup Analysis of the STELLAR Study.女性高胆固醇血症中他汀类药物治疗的比较:STELLAR研究的亚组分析
J Womens Health (Larchmt). 2016 Jan;25(1):50-6. doi: 10.1089/jwh.2015.5271. Epub 2015 Nov 5.
6
Rosuvastatin: a highly effective new HMG-CoA reductase inhibitor.瑞舒伐他汀:一种高效的新型HMG-CoA还原酶抑制剂。
Cardiovasc Drug Rev. 2002 Winter;20(4):303-28. doi: 10.1111/j.1527-3466.2002.tb00099.x.
7
Effects of rosuvastatin versus atorvastatin, simvastatin, and pravastatin on non-high-density lipoprotein cholesterol, apolipoproteins, and lipid ratios in patients with hypercholesterolemia: additional results from the STELLAR trial.瑞舒伐他汀与阿托伐他汀、辛伐他汀及普伐他汀对高胆固醇血症患者非高密度脂蛋白胆固醇、载脂蛋白及脂质比值的影响:STELLAR试验的额外结果
Clin Ther. 2004 Sep;26(9):1388-99. doi: 10.1016/j.clinthera.2004.09.006.
8
Response of rhesus serum high density lipoproteins to cycles of diet-induced hypercholesterolemia.恒河猴血清高密度脂蛋白对饮食诱导的高胆固醇血症循环的反应。
Arteriosclerosis. 1984 Mar-Apr;4(2):154-64. doi: 10.1161/01.atv.4.2.154.
9
Detrimental Effect of Hypercholesterolemia on High-Density Lipoprotein Particle Remodeling in Pigs.高胆固醇血症对猪高密度脂蛋白颗粒重塑的有害影响。
J Am Coll Cardiol. 2017 Jul 11;70(2):165-178. doi: 10.1016/j.jacc.2017.05.018.
10
Statin therapy alters the relationship between apolipoprotein B and low-density lipoprotein cholesterol and non-high-density lipoprotein cholesterol targets in high-risk patients: the MERCURY II (Measuring Effective Reductions in Cholesterol Using Rosuvastatin) trial.他汀类药物治疗改变高危患者载脂蛋白B与低密度脂蛋白胆固醇及非高密度脂蛋白胆固醇目标之间的关系:MERCURY II(使用瑞舒伐他汀测量胆固醇有效降低)试验
J Am Coll Cardiol. 2008 Aug 19;52(8):626-32. doi: 10.1016/j.jacc.2008.04.052.

引用本文的文献

1
Regel Enhances Serum Immunity, Antioxidant, and Biochemical Indicators of Meat Sheep Achieved by Rumen Microbiota Regulation.雷格尔通过调节瘤胃微生物群提高肉羊的血清免疫力、抗氧化能力和生化指标。
Animals (Basel). 2025 Aug 25;15(17):2491. doi: 10.3390/ani15172491.
2
HDL-Cholesterol and Triglycerides Dynamics: Essential Players in Metabolic Syndrome.高密度脂蛋白胆固醇与甘油三酯动态变化:代谢综合征中的关键因素
Antioxidants (Basel). 2025 Apr 3;14(4):434. doi: 10.3390/antiox14040434.
3
A comprehensive assessment of the association between common drugs and psychiatric disorders using Mendelian randomization and real-world pharmacovigilance database.

本文引用的文献

1
Protective effect of rosuvastatin pretreatment against acute myocardial injury by regulating Nrf2, Bcl-2/Bax, iNOS, and TNF-α expressions affecting oxidative/nitrosative stress and inflammation.瑞舒伐他汀预处理通过调节 Nrf2、Bcl-2/Bax、iNOS 和 TNF-α 的表达来防止急性心肌损伤,从而影响氧化/硝化应激和炎症。
Hum Exp Toxicol. 2022 Jan-Dec;41:9603271211066065. doi: 10.1177/09603271211066065.
2
Cholesterol Efflux Capacity and Its Association With Adverse Cardiovascular Events: A Systematic Review and Meta-Analysis.胆固醇流出能力及其与不良心血管事件的关联:一项系统评价和荟萃分析。
Front Cardiovasc Med. 2021 Dec 13;8:774418. doi: 10.3389/fcvm.2021.774418. eCollection 2021.
3
采用孟德尔随机化和真实世界药物警戒数据库全面评估常见药物与精神障碍之间的关联。
EBioMedicine. 2024 Sep;107:105314. doi: 10.1016/j.ebiom.2024.105314. Epub 2024 Aug 26.
4
The Influence of Metabolic Risk Factors on the Inflammatory Response Triggered by Myocardial Infarction: Bridging Pathophysiology to Treatment.代谢风险因素对心肌梗死后炎症反应的影响:将病理生理学与治疗联系起来。
Cells. 2024 Jun 29;13(13):1125. doi: 10.3390/cells13131125.
5
Pearls before Swine: Plant-Derived Wastes to Produce Low-Cholesterol Meat from Farmed Pigs-A Bibliometric Analysis Combined to Meta-Analytic Studies.对牛弹琴:利用植物源废弃物养殖低胆固醇猪肉的文献计量分析与荟萃分析
Foods. 2023 Jan 28;12(3):571. doi: 10.3390/foods12030571.
6
Crosstalk between high-density lipoproteins and endothelial cells in health and disease: Insights into sex-dependent modulation.健康与疾病状态下高密度脂蛋白与内皮细胞之间的相互作用:对性别依赖性调节的见解
Front Cardiovasc Med. 2022 Oct 6;9:989428. doi: 10.3389/fcvm.2022.989428. eCollection 2022.
Modification of High-Density Lipoprotein Functions by Diet and Other Lifestyle Changes: A Systematic Review of Randomized Controlled Trials.
饮食及其他生活方式改变对高密度脂蛋白功能的影响:随机对照试验的系统评价
J Clin Med. 2021 Dec 15;10(24):5897. doi: 10.3390/jcm10245897.
4
Unraveling the Complexity of HDL Remodeling: On the Hunt to Restore HDL Quality.解析高密度脂蛋白重塑的复杂性:致力于恢复高密度脂蛋白质量
Biomedicines. 2021 Jul 12;9(7):805. doi: 10.3390/biomedicines9070805.
5
Anti-inflammatory and Antioxidant Effects of Rosuvastatin on Asthmatic, Hyperlipidemic, and Asthmatic-Hyperlipidemic Rat Models.瑞舒伐他汀对哮喘、高脂血症及哮喘-高脂血症大鼠模型的抗炎和抗氧化作用
Inflammation. 2021 Dec;44(6):2279-2290. doi: 10.1007/s10753-021-01499-8. Epub 2021 Jul 6.
6
Regulation of the apolipoprotein M signaling pathway: a review.载脂蛋白 M 信号通路的调控:综述。
J Recept Signal Transduct Res. 2022 Jun;42(3):285-292. doi: 10.1080/10799893.2021.1924203. Epub 2021 May 18.
7
High Density Lipoprotein Cholesterol Efflux Capacity and Atherosclerosis in Cardiovascular Disease: Pathophysiological Aspects and Pharmacological Perspectives.高密度脂蛋白胆固醇外排能力与心血管疾病中的动脉粥样硬化:病理生理方面和药物治疗观点。
Cells. 2021 Mar 5;10(3):574. doi: 10.3390/cells10030574.
8
High-Density Lipoprotein Modifications: A Pathological Consequence or Cause of Disease Progression?高密度脂蛋白修饰:疾病进展的病理结果还是病因?
Biomedicines. 2020 Nov 28;8(12):549. doi: 10.3390/biomedicines8120549.
9
HDL (High-Density Lipoprotein) Remodeling and Magnetic Resonance Imaging-Assessed Atherosclerotic Plaque Burden: Study in a Preclinical Experimental Model.高密度脂蛋白(HDL)重塑与磁共振成像评估的动脉粥样硬化斑块负担:临床前实验模型研究。
Arterioscler Thromb Vasc Biol. 2020 Oct;40(10):2481-2493. doi: 10.1161/ATVBAHA.120.314956. Epub 2020 Aug 27.
10
Reporting animal research: Explanation and elaboration for the ARRIVE guidelines 2.0.报告动物研究:ARRIVE 指南 2.0 的解释和说明。
PLoS Biol. 2020 Jul 14;18(7):e3000411. doi: 10.1371/journal.pbio.3000411. eCollection 2020 Jul.